HomeDYN • NASDAQ
add
Dyne Therapeutics Inc
Previous close
$13.72
Day range
$13.40 - $14.24
Year range
$13.40 - $47.45
Market cap
1.39B USD
Avg Volume
1.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 105.66M | 69.67% |
Net income | -97.12M | -61.31% |
Net profit margin | — | — |
Earnings per share | -0.96 | 3.03% |
EBITDA | -105.22M | -70.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 723.67M | 358.54% |
Total assets | 768.84M | 274.60% |
Total liabilities | 63.30M | 18.98% |
Total equity | 705.54M | — |
Shares outstanding | 101.77M | — |
Price to book | 1.98 | — |
Return on assets | -33.13% | — |
Return on capital | -34.50% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -97.12M | -61.31% |
Cash from operations | -74.63M | -47.48% |
Cash from investing | -19.40M | -251.34% |
Cash from financing | 18.01M | 3,866.74% |
Net change in cash | -76.02M | -103.67% |
Free cash flow | -42.87M | -46.49% |
About
Founded
2017
Headquarters
Website
Employees
173
